Acadia Strategy Partners

About Acadia Strategy Partners

Acadia Strategy Partners is a biotech-focused advisory firm specializing in rare disease and gene therapy commercialization. They provide primary research and strategic insights to growing biotech companies and their investors to de-risk and accelerate decision-making across market access, payor strategy, and patient engagement. Their work spans early commercialization, patient advocacy, competitive analysis, patient journey deep dives, and real-world evidence to illuminate opportunities and threats in the rare disease landscape. Headquartered and active in the biotech hub ecosystem, they tailor engagements to diverse stakeholders including patients, clinicians, payors, and investors.